ViroGates A/S

Clinical trials sponsored by ViroGates A/S, explained in plain language.

ViroGates A/S VIRO COPENHAGEN

A Danish medical technology company developing diagnostic tests.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.

Completed 1

Blood test may predict COVID-19 severity, study finds

Knowledge-focused Completed

This study looked at whether a blood test measuring suPAR levels can predict which adults hospitalized with COVID-19 will develop severe breathing failure requiring a breathing tube. Researchers analyzed stored blood samples from about 367 patients. The goal was to see if a suPAR…

Sponsor: ViroGates A/S • Aim: Knowledge-focused

Last updated Jun 27, 2026 11:03 UTC

ViroGates A/S

Blood test may predict COVID-19 severity, study finds